Specialties

Metformin is often associated with lactic acidosis, especially in patients with kidney disease. A recently published study questions this association in patients with mild to moderate disease.

Canaglifozin reduced risk of cardiovascular death and hospitalizations due to heart failure by 31%.

Are you doing everything you can to ensure your patient has the best quality of life possible with type 2 diabetes?

SGLT-2 inhibitors show additional benefits besides lowering blood glucose.

Can an increase in waist circumference determine cardiovascular risk, separate from weight loss or gain?

Continuous glucose monitoring systems can enable pregnant women to monitor blood glucose more effectively. 

Use of metformin was associated with a 16% reduced risk for overall mortality in patients with type 2 diabetes and pancreatic cancer. 

Patients with T2DM may be at an increased risk of lower muscle performance and strength, putting them at risk for developing sarcopenia. 

Researchers found larger amount of gut microbiota in the digestive system of individuals with type 2 diabetes than in those without the disease. 

Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II receptor blockers (ARBs) can allow coronavirus entry, leading to pulmonary adverse effects.